Company Captor Therapeutics Spolka Akcyjna
Equities
CTX
PLCPTRT00014
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83 PLN | +3.75% | +2.22% | -16.16% |
Business Summary
Number of employees: 111
Sales per Business
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Research and Development
100.0
%
| 9 | 100.0 % | 13 | 100.0 % | +44.15% |
Sales per region
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Poland
100.0
%
| 9 | 100.0 % | 13 | 100.0 % | +44.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Shepherd
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | - | 21-05-31 | |
Chief Tech/Sci/R&D Officer | 39 | 19-11-21 | |
Maria Sagan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 20-04-07 | |
Director/Board Member | - | 21-12-31 | |
Chairman | 52 | 18-08-27 | |
Director/Board Member | - | 21-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,645,712 | 2,353,229 ( 50.65 %) | 0 | 50.65 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.16% | 91.72M | |
+22.66% | 42.68B | |
-3.32% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+8.10% | 24.94B | |
-20.18% | 18.96B | |
+29.39% | 12.3B | |
-2.87% | 11.95B | |
-1.63% | 11.55B |
- Stock Market
- Equities
- CTX Stock
- Company Captor Therapeutics Spolka Akcyjna